SARCOIDOSIS-LIKE SYNDROME IN A 44-YEAR-OLD WOMAN WITH ADVANCED STAGE MELANOMA TREATED WITH ADJUVANT BRAF PLUS MEK INHIBITORS. A CASE REPORT.
PDF (Spanish)

Keywords

melanoma
dabrafenib and trametinib
BRAF and MEK targeted therapy
immune-related adverse event
sarcoidosis
PDF (Spanish)
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 GaliciaClinica - Official Journal of the Galician Society of Internal Medicine (SOGAMI)